At a glance
Bristol Myers Squibb (BMS), a global biopharmaceutical company, was seeking FDA approval for its drug, Zeposia, to treat ulcerative colitis. For this to happen they needed an experienced team to focus on promotion and commercialisation.
BMS needed to build out an experienced field commercial team across the US comprising a diverse group of roles including: sales leadership and territory reps, medical science liasons and regional marketing directors.
These hires were to support the commercialisation of Zeposia for ulcerative colitis (UC).
Hiring needed to be completed within a 6 month window.
AMS helped support this critical and time sensitive program of specialised growth enabling BMS to hire and train staff in a timely fashion in order to meet timelines.